| 1. | Platelet rich plasma and bone regeneration
富血小板血浆与骨再生 |
| 2. | The clinical use of platelet rich plasma in stomatology
富血小板血浆对表面多孔性种植体周骨再生的作用 |
| 3. | Repair of segmental bone defects by tissue engineering and guided bone regeneration
组织工程引导骨再生膜修复节段性骨缺损 |
| 4. | Using platelet - rich plasma to improve bone regeneration in implant bone defect
富血小板血浆促进口腔种植骨再生的临床应用研究 |
| 5. | Clinical observations on stimulative effect of bone marrow autografting and oral
自体骨髓移植配合骨疏康内服对促进骨再生作用的临床观察 |
| 6. | The clinical application and effect of bone formation by means of transplanting osteoblast and basic fibroblast growth factor
成骨细胞和碱性成纤维细胞生长因子植入促进骨再生过程研究 |
| 7. | Another exigency inoles the carrying out of the mechanical functions of the damaged bone while the desired regeneration takes place
另一亟需解决的是当所期望的骨再生发生时，它能执行受损骨组织的机械功能。 |
| 8. | The goal is to come up with a substitute for bone tissue that can put the bone right and regenerate in such a way that it carries out similar functions as in its natural state
目标是达到骨组织替代物的要求? ?可校正骨骼以及促进骨再生，与自然状态下组织的功能相似。 |
| 9. | Human bone morphogenetic protein 3 is a member of tgf - b superfamily . lt can induce the differentiation of cartilage and bone tissue in mesenchymal cell . and is important to bone self - repairment and bone development during embryo morphogenesis . in addition , some other biological activities of hbmp - 3 have also been found . such as inducing development of embryo and stimulating differentiation of neural and blood cells . therefore , there is a great prospect in the use of hbmp - 3 . there is trace content of hbmp - 3 in human body . it has been expressed in the expression system of eukaryotes and prokaryotes respectively , but its application is restricted because of defects in the process and modification after translation in prokaryotic cells and higher costs and lower yields existed in eukaryotic expression system
人骨形成蛋白3 ( hbmp - 3 )属于tgf -超家族的一员，可以诱导间充质细胞分化为软骨和骨，在胚胎时期骨骼发育和骨再生修复中起着重要的作用，而且对胚胎发育过程中中胚层的诱导和分化、造血组织的发育以及神经系统的发育和修复等都起着重要作用，因而hbmp - 3有广阔的市场前景。它在人体内含量极微，尽管研究人员已经在原核细胞和真核细胞表达系统中分别进行了表达，但是由于原核表达系统缺乏翻译后的加工修饰，真核表达系统存在成本高、产量低等特点，限制了其在临床上的应用。 |
